BioCentury
ARTICLE | Company News

Curna Inc., Opko deal

February 7, 2011 8:00 AM UTC

Opko Health acquired Curna for $10 million in cash. Curna's AntagoNAT drug discovery platform up-regulates therapeutic proteins through interference with non-coding RNAs. Curna spun out of and subsequ...